期刊
EXPERT OPINION ON THERAPEUTIC TARGETS
卷 13, 期 1, 页码 93-104出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/14728220802607363
关键词
metastatic melanoma; RaLP; Shc family; targeted inhibitors
资金
- Programma Straordinario Oncologia 2006 Italian Ministry of Health Institute [N ACC12, N 22-07]
- Italian Association for Cancer Research (AIRC)
- Fondazione Cariplo (NOBEL)
Background: Metastatic melanoma remains one of the most aggressive forms of cancer, with a survival expectation of above six months only in rare cases. Despite advances in the characterization of the underlying molecular pathways and in the development of specific targeted treatments, available chemo- and immuno-therapy are unable to prolong survival significantly in advanced-stage melanoma. Rai like protein (RaLP) is a newly identified Src homology 2 domain containing (Shc) family member selectively expressed during the transition to metastatic melanoma and thus is a potential melanoma-specific drugable target. Objective: To summarize progress in the ongoing therapeutic approaches to metastatic melanoma and discuss RaLP as a potential novel therapeutic target. Methods: Current understanding of the major signaling pathways involved in melanoma metastatization and of the corresponding pharmacological inhibitors is discussed. Conclusion: RaLP might represent a new drugable target for the treatment of metastatic disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据